During the past decade, Weifang Asthma Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Weifang Asthma Hospital" are "Airway Responsiveness" (2 trials), "Asthma" (2 trials), "Chest Syndrome" (2 trials), "Clinical Anxiety" (2 trials) and "Clinical Depression" (2 trials). Many other conditions were trialed in "Weifang Asthma Hospital" in a lesser frequency.

Most popular intervention types in "Weifang Asthma Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Inhaled corticosteriod/long-acting beta-agonist only" (1 trials), "Inhaled corticosteriod/long-acting beta-agonist plus Montelukast" (1 trials) and "Treat patient according to Global Initiative for Asthma (GINA) guideline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Weifang Asthma Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Weifang Asthma Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Weifang Asthma Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Weifang Asthma Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".